A randomized, open-label, single dose, phase 1 study to evaluate the safety, tolerability, food effect, and pharmacokinetic characteristics of DA-9701 in healthy volunteers

Trial Profile

A randomized, open-label, single dose, phase 1 study to evaluate the safety, tolerability, food effect, and pharmacokinetic characteristics of DA-9701 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs DA 9701 (Primary)
  • Indications Constipation; Non-ulcer dyspepsia
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Dong-A ST
  • Most Recent Events

    • 15 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top